The U.S. Food and Drug Administration (FDA) Division of Neurology Products, in conjunction with the Pharmaceutical Education & Research Institute Inc. (PERI), will host the Safety and Efficacy of Hypnotic Drugs workshop May 10-11, 2011, at the Bethesda Marriott Hotel in Bethesda, Md. The first day of the workshop will focus on the definition of insomnia, study population selection, end-points and efficacy assessments. The second day will center on the safety of insomnia drugs, in particular on the assessment of next-day function, including psychomotor vigilance and driving testing. For more information visit the PERI website at www.peri.org or send an e-mail to email@example.com. To register for this workshop (course #Y26), call the PERI Registrar at 703-276-0178. AASM members can receive a $100 discount off published course rates by using the registration code “AASMY26” when you register by phone.
Safety and Efficacy of Hypnotic Drugs Workshop is May 10-11
July 2nd, 2021 | 0 Comments
June 24th, 2021 | 0 Comments
June 10th, 2021 | 0 Comments